CD8A and neoplasm: In order to assess the cost, as measured by variability, associated with using a core biopsy sample instead of a tumor cross-section, we performed virtual biopsy sampling from within slides and compared biopsy-based CD8+ cell prevalence to slide- and block-based measurements of staining.